AU Patent

AU2019263302C1 — Liquid depot for non-invasive sustained delivery of agents to the eye

Assigned to Chibi Inc · Expires 2024-10-31 · 2y expired

What this patent protects

The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical ag…

USPTO Abstract

The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical agent to the eye for days or weeks.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019263302C1
Jurisdiction
AU
Classification
—
Expires
2024-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Chibi Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.